Concepedia

Li‐Min Wang

LW

Statistics

Publications

6

Citations

320

H-Index

6

Active since

2010

Affiliations

Shanghai Institute of Materia Medica(Current)

University of Chinese Academy of Sciences

Li‐Min Wang is an author at Shanghai Institute of Materia Medica specializing in molecular oncology, poly adp-ribose polymerase inhibitors, and life sciences.

ORCID

Publications per year

2010–2023

6

Publications

6

1B50-1, a mAb Raised against Recurrent Tumor Cells, Targets Liver Tumor-Initiating Cells by Binding to the Calcium Channel α2δ1 Subunit

Wei Zhao, Li‐Min Wang, Haibo Han et al. · Cancer Cell · 2013 · 180 citations · Full text

, , +15

Binding of curcumin to barley protein Z improves its solubility, stability and bioavailability

Z. Gordon Jiang, Jing Gan, Li‐Min Wang et al. · Food Chemistry · 2022 · 47 citations

, , +7

Thioparib inhibits homologous recombination repair, activates the type I IFN response, and overcomes olaparib resistance

Li‐Min Wang, Pingyuan Wang, Hui Yang et al. · EMBO Molecular Medicine · 2023 · 44 citations · Full text

, , +16

Enzyme entrapped nanoporous scaffolds formed through flow-induced gelation in a microfluidic filter device for sensitive biosensing of organophosphorus compounds

Donglai Lu, Guocheng Shao, Dan Du et al. · Lab on a Chip · 2010 · 21 citations · Full text

, , +17

YCH1899, a Highly Effective Phthalazin-1(2<i>H</i>)-one Derivative That Overcomes Resistance to Prior PARP Inhibitors

Yuting Sun, Hui Yang, Jiaqi Yuan et al. · Journal of Medicinal Chemistry · 2023 · 16 citations · Full text

, , +13

1–5 of 6